R-Bio

1 in Phase 3

Quick facts

Phase 3 pipeline

JOINTSTEM · Orthopedics / Rheumatology
JOINTSTEM is an autologous mesenchymal stem cell therapy that promotes cartilage regeneration and reduces inflammation in damaged joints.

Phase 1 pipeline

RNL-Vascostem®

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: